Hello and welcome to Talking TBIs! Join me as I discuss what’s new in traumatic brain injury research and highlight current problems in TBI diagnosis. This series will focus on the use of serum biomarker tests for detection of brain injury and potential changes in practice to come.
Podcast Overview
Hello and welcome to Talking TBIs! Join me as I discuss what’s new in traumatic brain injury research and highlight current problems in TBI diagnosis. This series will focus on the use of serum biomarker tests for detection of brain injury and potential changes in practice to come.
Language
🇺🇲
Publishing Since
8/5/2021
1 verified contact email on file for Talking TBIs
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
August 5, 2021
Talking TBIs Episode 3: Potential changes to clinical practice
<p>Hello and welcome back to Talking TBIs. This third episode will discuss the implementation of serum biomarkers into the workup of a patient with suspected head injury and the future of serum biomarker tests in clinical practice. </p>
August 5, 2021
Talking TBIs Episode 2: an update on new research
<p>Hello and welcome back to Talking TBIs. This second episode has lots of information regarding some of the research that has been conducted on three biomarkers I have chosen to talk about. I will discuss S100B, GFAP, and UCHL-1 and their ability to detect TBI as well as estimate prognosis.</p>
August 5, 2021
Talking TBIs Episode 1: What is happening now?
<p>Hello and welcome to Talking TBIs! Join me as I discuss the potential of serum biomarker tests for detection and prognosis of brain injury. This first episode with go over the current work up of TBI patients in the ED as well as epidemiology and management. I will also highlight the problems in TBI diagnoses currently, and how serum biomarker tests may fill this gap. Stay tuned for more episodes. For episode links, show notes, and research included in this podcast, please visit www.talkingtbis.wordpress.com</p>
3 total episodes available
Deep-dive analytics for Talking TBIs
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Talking TBIs?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.